首页 | 本学科首页   官方微博 | 高级检索  
     

万拉法新与氯硝安定治疗广泛性焦虑症的疗效比较
引用本文:刘延梅,于斌,王欣,林卫. 万拉法新与氯硝安定治疗广泛性焦虑症的疗效比较[J]. 四川精神卫生, 2006, 19(2): 87-88
作者姓名:刘延梅  于斌  王欣  林卫
作者单位:266034,山东省青岛市精神卫生中心;266034,山东省青岛市精神卫生中心;266034,山东省青岛市精神卫生中心;266034,山东省青岛市精神卫生中心
摘    要:目的评价万拉法新治疗广泛性焦虑症的临床疗效和不良反应方法将76例符合CCMD-3诊断标准的广泛性焦虑症患者随机分为两组,分别应用万拉法新(38例)、氯硝安定(38例)进行对照治疗。疗程6周。采用焦虑自评量表(SAS)、Hamilton焦虑量表(HAMA)和不良反应量表(TESS)评定疗效和不良反应。结果万拉法新与氯硝安定对广泛性焦虑症均有显著疗效,两组间疗效无显著性差异(P〉0.05),万拉法新不良反应明显少于氯硝安定(P〈0.01)。结论万拉法新治疗广泛性焦虑症安全有效,不良反应少。

关 键 词:万拉法新  广泛性焦虑症  氯硝安定
文章编号:1007-3256(2006)02-0087-02
收稿时间:2005-12-08
修稿时间:2005-12-08

A comparative study of venlafaxine and clonazepam in the treatment of patients with generalized anxiety disorder
LIU Yanmei , YU Bin, WANG Xin ,et al. A comparative study of venlafaxine and clonazepam in the treatment of patients with generalized anxiety disorder[J]. Sichuan Mental Health, 2006, 19(2): 87-88
Authors:LIU Yanmei    YU Bin   WANG Xin   et al
Affiliation:Qingdao Mental Health Center ,Shandong 266034, China
Abstract:Objective To evaluate the efficacy and side effects of venlafaxine in the treatment of generalized anxiety disorder. Methods 76 patients who met the criteria of CCMD - 3 for generalized anxiety disorder were randomly assigned into venlafaxine group and clonazepam group for treatment of 6 weeks. The efficacy and side effects of two groups were assessed by HAMD, SAS and TESS. Results Both drugs had marked efficacy in the treatment of generalized anxiety disorder. Conclusion Venlafaxine is a safe and efficient drug with fewer side effects for the treatment of generalized anxiety disorder.
Keywords:Venlafaxine Anxiety Clonazepam
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号